Showing 2 posts of 2 posts found.
GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …
The FDA has cleared Genzyme to begin production of Fabrazyme at its new manufacturing site. The approval of the new …
How chronic disease creates opportunity on diagnostic and therapeutic pipelines
EnteroBiotix appoints former GSK Chief Medical Officer to board
Stryker invests US$400m in CMR Surgical and secures option to acquire business
AI: an early warning system for patient safety
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial